Literature DB >> 15080629

Performance and applications of polyclonal antipeptide antibodies specific for the enterococcal bacteriocin enterocin P.

Jorge Gutiérrez1, Raquel Criado, Rosanna Citti, María Martín, Carmen Herranz, María F Fernández, Luis M Cintas, Pablo E Hernández.   

Abstract

Polyclonal antibodies with specificity for enterocin P (EntP) have been generated by immunization of rabbits with two chemically synthesized N-terminal peptides (P1 and P2) and a C-terminal peptide (P3) of this bacteriocin conjugated to the carrier protein KLH. The sensitivity and specificity of the peptide-KLH-generated antibodies were evaluated by a noncompetitive indirect enzyme-linked immunosorbent assay (NCI-ELISA) and a competitive indirect (CI)-ELISA. The NCI-ELISA but not the CI-ELISA was valuable for detecting the existence of EntP specific antibodies in the sera of the P2-KLH and P3-KLH immunized animals and to detect and quantify the EntP in the supernatant of producer strains. The anti-P2-KLH sera cross-reacted with the supernatant of a strain producer of sakacin A, a bacteriocin closely related to EntP. Immunoaffinity chromatography columns with anti-P2-KLH or anti-P3-KLH immunoglobulins retained the EntP from the supernatant of the producer strain. Western blotting of EntP with the anti-P2-KLH-generated antibodies suggests that purified EntP tends to the formation of aggregates with no antimicrobial activity. Monitoring the purification of EntP with antipeptide antibodies suggests that while the performance of the evaluated purification procedures would be reasonably acceptable in terms of recovery of the antimicrobial activity of the bacteriocin, their yield is far from attractive in terms of recovery of the initial concentration of enterocin P.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15080629     DOI: 10.1021/jf030551j

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  8 in total

1.  Use of the yeast Pichia pastoris as an expression host for secretion of enterocin L50, a leaderless two-peptide (L50A and L50B) bacteriocin from Enterococcus faecium L50.

Authors:  Antonio Basanta; Beatriz Gómez-Sala; Jorge Sánchez; Dzung B Diep; Carmen Herranz; Pablo E Hernández; Luis M Cintas
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

2.  Complete sequence of the enterocin Q-encoding plasmid pCIZ2 from the multiple bacteriocin producer Enterococcus faecium L50 and genetic characterization of enterocin Q production and immunity.

Authors:  Raquel Criado; Dzung B Diep; Agot Aakra; Jorge Gutiérrez; Ingolf F Nes; Pablo E Hernández; Luis M Cintas
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

3.  Immunochemical characterization of temperature-regulated production of enterocin L50 (EntL50A and EntL50B), enterocin P, and enterocin Q by Enterococcus faecium L50.

Authors:  Raquel Criado; Jorge Gutiérrez; María Martín; Carmen Herranz; Pablo E Hernández; Luis M Cintas
Journal:  Appl Environ Microbiol       Date:  2006-10-20       Impact factor: 4.792

4.  Production of enterocin P, an antilisterial pediocin-like bacteriocin from Enterococcus faecium P13, in Pichia pastoris.

Authors:  Jorge Gutiérrez; Raquel Criado; María Martín; Carmen Herranz; Luis M Cintas; Pablo E Hernández
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Development of bacteriocinogenic strains of Saccharomyces cerevisiae heterologously expressing and secreting the leaderless enterocin L50 peptides L50A and L50B from Enterococcus faecium L50.

Authors:  Antonio Basanta; Carmen Herranz; Jorge Gutiérrez; Raquel Criado; Pablo E Hernández; Luis M Cintas
Journal:  Appl Environ Microbiol       Date:  2009-02-13       Impact factor: 4.792

6.  Cloning and heterologous production of Hiracin JM79, a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in lactic acid bacteria and Pichia pastoris.

Authors:  Jorge Sánchez; Juan Borrero; Beatriz Gómez-Sala; Antonio Basanta; Carmen Herranz; Luis M Cintas; Pablo E Hernández
Journal:  Appl Environ Microbiol       Date:  2008-02-29       Impact factor: 4.792

7.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

Review 8.  Peptides, Antibodies, Peptide Antibodies and More.

Authors:  Nicole Trier; Paul Hansen; Gunnar Houen
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.